Chardan Downgrades Passage Bio Inc. (PASG) to Neutral

April 21, 2026 3:20 AM

Chardan analyst Gbola Amusa downgraded Passage Bio Inc. (NASDAQ: PASG) from Buy to Neutral with a price target of $7.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found